directCHECK Whole Blood Controls DCJACT-ARecalls & reported problems
Accriva Diagnostics Holdings, Inc. · directCHECK ACT+ Abnormal 15/box · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10711234107058), received between Nov 2, 2017 and Nov 2, 2017 — classified as 1 malfunction.
The most frequently reported specific device problem is “Improper or Incorrect Procedure or Method” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Improper or Incorrect Procedure or Method1
Patient problems
- Laceration(s)1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionNov 2, 2017Improper or Incorrect Procedure or Method; Adverse Event Without Identified Device or Use Problem; Improper or Incorrect Procedure or Method; Adverse Event Without Identified Device or Use Problem
HEALTHCARE PROFESSIONAL REPORTED THAT AN END USER SUSTAINED AN INJURY DURING RECONSTITUTION OF A DIRECTCHECK QUALITY CONTROL. THIS CONTROL IS PACKAGED IN A GLASS AMPULE INSIDE A CRUSHABLE PLASTIC DROPPED VIAL CONTAINING DILUENT. THE END-USER WAS NOT WEARING GLOVES AND DID NOT USE THE PROTECTIVE SLEEVE PROVIDED WITH THE PRODUCT. THE PURPOSE OF THE SLEEVE IS TO SAFEGUARD END USERS AGAINST POTENTIAL INJURY DURING RECONSTITUTION OF THE CONTROL. WHEN CRUSHING THE VIAL, A GLASS SHARD PROTRUDED THROUGH THE DROPPER VIAL AND PUNCTURED THE USER'S RIGHT THUMB. THE END USER IMMEDIATELY WASHED THE AREA WITH SOAP AND WATER AND COVERED THE CUT WITH A BAND AID. NO FURTHER MEDICAL ATTENTION WAS SOUGHT. NO SIGNIFICANT BLOOD LOSS OR MEDICAL COMPLICATIONS WERE REPORTED.
Patient problems: Laceration(s)
MAUDE report 6996101 ↗
Other Plasma, Coagulation Control devices
- STA® - System Control N + P 00678Diagnostica Stago · PLASMA, COAGULATION CONTROL1 recall0 reports
- directCHECK ACT-LR Whole Blood Control, Level 2 000DCGLR-2Accriva Diagnostics Holdings, Inc. · Plasma, Coagulation Control1 recall0 reports
- 5-PLASMA Bivalirudin Control 5D-449055-Diagnostics Ltd · Plasma, Coagulation Control1 recall0 reports
- BIOPHEN UFH Control Plasma 223101Hyphen Biomed · Plasma, Coagulation Control1 recall0 reports
- directCHECK Whole Blood Controls DCJLR-AAccriva Diagnostics Holdings, Inc. · Plasma, Coagulation Control5 reports
- directCHECK Whole Blood Controls DCJLR-NAccriva Diagnostics Holdings, Inc. · Plasma, Coagulation Control2 reports
- Control Plasma N 10446235Siemens Healthcare Diagnostics Products GmbH · PLASMA, COAGULATION CONTROL1 report
- directCHECK Whole Blood Controls DCJCPT-AAccriva Diagnostics Holdings, Inc. · Plasma, Coagulation Control1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page